Zobrazeno 1 - 10 of 499 pro vyhledávání: '"NL Letvin"'
1
Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals
Autor: Rh, Vonderheide, Joachim Schultze, Ks, Anderson, Maecker B, Mo, Butler, Xia Z, Mj, Kuroda, Ms, Bergwelt-Baildon, Mm, Bedor, Km, Hoar, Dr, Schnipper, Mw, Brooks, Nl, Letvin, Kf, Stephans, Kw, Wucherpfennig, Wc, Hahn, Lm, Nadler
Publikováno v: Europe PubMed Central
Although high frequencies of T lymphocytes specific for certain tumor-associated antigens have been detected in some cancer patients, increasing evidence suggests that these T cells may be functionally defective in vivo and fail to induce meaningful
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::6ecdc8c5d124f04025f04996f7816f34
https://pubmed.ncbi.nlm.nih.gov/11731409
Zobrazit plný text záznamu
2
Simian immunodeficiency virus-specific cytotoxic T lymphocytes and cell-associated viral RNA levels in distinct lymphoid compartments of SIVmac-infected rhesus monkeys
Autor: Mj, Kuroda, Joern E Schmitz, Seth A, Rs, Veazey, Ce, Nickerson, Ma, Lifton, Pj, Dailey, Ma, Forman, Racz P, Tenner-Racz K, Nl, Letvin
Publikováno v: Europe PubMed Central
Major histocompatibility class I-peptide tetramer technology and simian immunodeficiency virus of macaques (SIVmac)-infected rhesus monkeys were used to clarify the distribution of acquired immunodeficiency syndrome virus-specific cytotoxic T lymphoc
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::668457d1a2698654e4e730c155bad843
https://pubmed.ncbi.nlm.nih.gov/10942394
Zobrazit plný text záznamu
5
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates: I. Effects of anti-T11 antibodies on the circulating T cell pool
Autor: NL Letvin, J Ritz, LJ Guida, JM Yetz, JM Lambert, EL Reinherz, SF Schlossman
Publikováno v: Blood. 66(4)
The effects of in vivo administration of three monoclonal antibodies specific for T11, the E rosette receptor on T lymphocytes, were examined in the rhesus monkey (Macaca mulatta). These three monoclonal antibodies were of different isotypes and were
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cfad83dfedcf4c023f9facb2c3d99b5
https://pubmed.ncbi.nlm.nih.gov/3876127
Zobrazit plný text záznamu
6
Expression of the CD8alpha beta-heterodimer on CD8(+) T lymphocytes in peripheral blood lymphocytes of human immunodeficiency virus- and human immunodeficiency virus+ individuals
Autor: Joern E Schmitz, Ma, Forman, Ma, Lifton, Concepción O, Ka, Reimann, Cs, Crumpacker, Jf, Daley, Rs, Gelman, Nl, Letvin
Publikováno v: Europe PubMed Central
CD8(+) T lymphocytes play a pivotal role in controlling human immunodeficiency virus (HIV)-1 replication in vivo. We have performed four-color flow cytometric analysis of CD8(+) peripheral blood lymphocytes (PBL) from 21 HIV-1 seronegative and 103 se
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7096f4efe89feffd771093d3a8f69578
http://europepmc.org/abstract/med/9639517
Zobrazit plný text záznamu
7
Akademický článek
Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Autor: Reddi TS; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, United States of America., Merkl PE; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, United States of America., Lim SY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Letvin NL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America., Knipe DM; Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, Massachusetts, United States of America.
Publikováno v: PLoS pathogens [PLoS Pathog] 2021 Feb 01; Vol. 17 (2), pp. e1009281. Date of Electronic Publication: 2021 Feb 01 (Print Publication: 2021).
Zobrazit plný text záznamu
8
Akademický článek
Recombinant MVA-prime elicits neutralizing antibody responses by inducing antigen-specific B cells in the germinal center.
Autor: Eslamizar L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Integrative Toxicology, Nonclinical Drug Safety, Boehringer Ingelheim Pharmaceuticals, Inc., 175 Briar Ridge Road, Ridgefield, CT, 06877, USA., Petrovas C; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA. Konstantinos.Petrovas@chuv.ch.; Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University, Lausanne, Switzerland. Konstantinos.Petrovas@chuv.ch., Leggat DJ; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Furr K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Lifton ML; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Levine G; Foundation for the National Institutes of Health, Bethesda, MD, USA., Ma S; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Fletez-Brant C; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Hoyland W; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Prabhakaran M; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Narpala S; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Boswell K; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Yamamoto T; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Liao HX; Foundation for the National Institutes of Health, Bethesda, MD, USA., Pickup D; Duke Human Vaccine Institute, Durham, NC, USA., Ramsburg E; Duke Human Vaccine Institute, Durham, NC, USA., Sutherland L; Duke Human Vaccine Institute, Durham, NC, USA., McDermott A; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Roederer M; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Montefiori D; Duke Human Vaccine Institute, Durham, NC, USA., Koup RA; Vaccine Research Center, NIAID, NIH, Bethesda, MD, USA., Haynes BF; Duke Human Vaccine Institute, Durham, NC, USA., Letvin NL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA., Santra S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. ssantra@bidmc.harvard.edu.
Publikováno v: NPJ vaccines [NPJ Vaccines] 2021 Jan 25; Vol. 6 (1), pp. 15. Date of Electronic Publication: 2021 Jan 25.
Zobrazit plný text záznamu
9
Akademický článek
Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates.
Autor: Saunders KO; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.saunders@dm.duke.edu., Nicely NI; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Wiehe K; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Bonsignori M; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Meyerhoff RR; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Parks R; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Walkowicz WE; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA., Aussedat B; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA., Wu NR; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Cai F; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Vohra Y; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA., Park PK; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA., Eaton A; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Go EP; University of Kansas, Lawrence, KS 66045, USA., Sutherland LL; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Scearce RM; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Zhang R; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Von Holle T; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Overman RG; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Anasti K; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Sanders RW; Department of Medical Microbiology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands., Moody MA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Kepler TB; Boston University, Boston, MA 02215, USA., Korber B; LANL, Los Alamos, NM 87545, USA., Desaire H; University of Kansas, Lawrence, KS 66045, USA., Santra S; Harvard Medical School, Boston, MA, 02215, USA., Letvin NL; Harvard Medical School, Boston, MA, 02215, USA., Nabel GJ; Sanofi, Cambridge, MA 02139, USA., Montefiori DC; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA., Tomaras GD; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Liao HX; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Alam SM; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Danishefsky SJ; Sloan Kettering Institute for Cancer Research, New York, NY 10065, USA., Haynes BF; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.
Publikováno v: Cell reports [Cell Rep] 2017 Feb 28; Vol. 18 (9), pp. 2175-2188.
Zobrazit plný text záznamu
10
Akademický článek
Tissue memory B cell repertoire analysis after ALVAC/AIDSVAX B/E gp120 immunization of rhesus macaques.
Autor: Luo K; Duke Human Vaccine Institute., Liao HX; Duke Human Vaccine Institute.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.; College of Life Science and Technology, Jinan University, Guangzhou, China., Zhang R; Duke Human Vaccine Institute., Easterhoff D; Duke Human Vaccine Institute., Wiehe K; Duke Human Vaccine Institute., Gurley TC; Duke Human Vaccine Institute., Armand LC; Duke Human Vaccine Institute., Allen AA; Duke Human Vaccine Institute., Von Holle TA; Duke Human Vaccine Institute., Marshall DJ; Duke Human Vaccine Institute., Whitesides JF; Duke Human Vaccine Institute., Pritchett J; Duke Human Vaccine Institute., Foulger A; Duke Human Vaccine Institute., Hernandez G; Duke Human Vaccine Institute., Parks R; Duke Human Vaccine Institute., Lloyd KE; Duke Human Vaccine Institute., Stolarchuk C; Duke Human Vaccine Institute., Sawant S; Duke Human Vaccine Institute., Peel J; Duke Human Vaccine Institute., Yates NL; Duke Human Vaccine Institute., Dunford E; Duke Human Vaccine Institute., Arora S; Duke Human Vaccine Institute., Wang A; Duke Human Vaccine Institute., Bowman CM; Duke Human Vaccine Institute., Sutherland LL; Duke Human Vaccine Institute., Scearce RM; Duke Human Vaccine Institute., Xia SM; Duke Human Vaccine Institute., Bonsignori M; Duke Human Vaccine Institute.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Pollara J; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Edwards RW; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Santra S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Letvin NL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA., Tartaglia J; Sanofi-Pasteur, Swiftwater, Pennsylvania, USA., Francis D; Global Solutions for Infectious Diseases, South San Francisco, California, USA., Sinangil F; Global Solutions for Infectious Diseases, South San Francisco, California, USA., Lee C; Global Solutions for Infectious Diseases, South San Francisco, California, USA., Kaewkungwal J; Center of Excellence for Biomedical and Public Health Informatics BIOPHICS, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Nitayaphan S; Armed Forces Research Institute of Medical Sciences-Royal Thai Army Component, Bangkok, Thailand., Pitisuttithum P; Mahidol University, Bangkok, Thailand., Rerks-Ngarm S; Department of Disease Control, Ministry of Public Health, Nonthaburi, Thailand., Michael NL; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Kim JH; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA., Alam SM; Duke Human Vaccine Institute.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Department of Pathology., Vandergrift NA; Duke Human Vaccine Institute.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA., Ferrari G; Duke Human Vaccine Institute.; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Montefiori DC; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA., Tomaras GD; Duke Human Vaccine Institute.; Department of Surgery, Duke University Medical Center, Durham, North Carolina, USA.; Department of Immunology., Haynes BF; Duke Human Vaccine Institute.; Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA.; Department of Immunology., Moody MA; Duke Human Vaccine Institute.; Department of Immunology.; Department of Pediatrics, Duke University Medical Center, Durham, North Carolina, USA.
Publikováno v: JCI insight [JCI Insight] 2016 Dec 08; Vol. 1 (20), pp. e88522. Date of Electronic Publication: 2016 Dec 08.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje